These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 26607995)
1. Effect of preoperative chemotherapy on survival of patients with upper urinary tract urothelial carcinoma clinically involving regional lymph nodes. Kobayashi K; Saito T; Kitamura Y; Bilim V; Toba T; Kawasaki T; Hara N; Tanikawa T; Tomita Y Int J Urol; 2016 Feb; 23(2):153-8. PubMed ID: 26607995 [TBL] [Abstract][Full Text] [Related]
2. A role for preoperative systemic chemotherapy in node-positive upper tract urothelial carcinoma treated with radical nephroureterectomy. Kitamura H; Igarashi M; Tanaka T; Shindo T; Masumori N; Tamakawa M; Kawaai Y; Tsukamoto T Jpn J Clin Oncol; 2012 Dec; 42(12):1192-6. PubMed ID: 23077244 [TBL] [Abstract][Full Text] [Related]
3. Effect of Adjuvant Systemic Chemotherapy on Intravesical Recurrence After Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma. Yamaguchi N; Morizane S; Yumioka T; Shimizu R; Teraoka S; Iwamoto H; Hikita K; Honda M; Takenaka A Anticancer Res; 2023 Apr; 43(4):1725-1730. PubMed ID: 36974830 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration. Hellenthal NJ; Shariat SF; Margulis V; Karakiewicz PI; Roscigno M; Bolenz C; Remzi M; Weizer A; Zigeuner R; Bensalah K; Ng CK; Raman JD; Kikuchi E; Montorsi F; Oya M; Wood CG; Fernandez M; Evans CP; Koppie TM J Urol; 2009 Sep; 182(3):900-6. PubMed ID: 19616245 [TBL] [Abstract][Full Text] [Related]
5. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma. Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626 [TBL] [Abstract][Full Text] [Related]
6. Impact of an adjuvant chemotherapeutic regimen on the clinical outcome in high risk patients with upper tract urothelial carcinoma: a Japanese multi-institution experience. Shirotake S; Kikuchi E; Tanaka N; Matsumoto K; Miyazaki Y; Kobayashi H; Ide H; Obata J; Hoshino K; Kaneko G; Hagiwara M; Kosaka T; Kanao K; Kodaira K; Hara S; Oyama M; Momma T; Miyajima A; Nakagawa K; Hasegawa S; Nakajima Y; Oya M J Urol; 2015 Apr; 193(4):1122-8. PubMed ID: 25444957 [TBL] [Abstract][Full Text] [Related]
7. Role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma and the prognostic significance of C-reactive protein: A multi-institutional, retrospective study. Fujita K; Inamoto T; Yamamoto Y; Tanigawa G; Nakayama M; Mori N; Tsujihata M; Azuma H; Nonomura N; Uemura M Int J Urol; 2015 Nov; 22(11):1006-12. PubMed ID: 26153093 [TBL] [Abstract][Full Text] [Related]
8. Impact of adjuvant chemotherapy in patients with upper tract urothelial carcinoma and lymphovascular invasion after radical nephroureterectomy. Lee KS; Kim KH; Yoon YE; Choi KH; Yang SC; Han WK Korean J Urol; 2015 Jan; 56(1):41-7. PubMed ID: 25598935 [TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis predicts poor clinical outcomes in patients with node-negative upper urinary tract urothelial carcinoma. Zhang XK; Zhang ZL; Yang P; Cai MY; Hu WM; Yun JP; Zhou FJ; Qian CN; Cao Y Jpn J Clin Oncol; 2015 Nov; 45(11):1069-75. PubMed ID: 26355163 [TBL] [Abstract][Full Text] [Related]
10. Optimizing the Sequence of Chemotherapy for Upper Tract Urothelial Carcinoma with Clinically Positive Regional Lymph Nodes. Chakiryan N; Martinez A; Gao L; Liu JJ; Amling C; Garzotto M; Kopp RP J Urol; 2019 Jul; 202(1):76-82. PubMed ID: 30925108 [TBL] [Abstract][Full Text] [Related]
11. Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma. Liao RS; Gupta M; Schwen ZR; Patel HD; Kates M; Johnson MH; Hahn NM; McConkey D; Bivalacqua TJ; Pierorazio PM J Urol; 2018 Jul; 200(1):68-73. PubMed ID: 29307680 [TBL] [Abstract][Full Text] [Related]
12. Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A. Inokuchi J; Kuroiwa K; Kakehi Y; Sugimoto M; Tanigawa T; Fujimoto H; Gotoh M; Masumori N; Ogawa O; Eto M; Ohyama C; Yamaguchi A; Matsuyama H; Ichikawa T; Asano T; Mizusawa J; Eba J; Naito S World J Urol; 2017 Nov; 35(11):1737-1744. PubMed ID: 28508102 [TBL] [Abstract][Full Text] [Related]
13. Does lymph node dissection during nephroureterectomy affect oncological outcomes in upper tract urothelial carcinoma patients without suspicious lymph node metastasis on preoperative imaging studies? Yoo S; You D; Jeong IG; Hong B; Hong JH; Ahn H; Kim CS World J Urol; 2017 Apr; 35(4):665-673. PubMed ID: 27502934 [TBL] [Abstract][Full Text] [Related]
14. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract. Kondo T; Nakazawa H; Ito F; Hashimoto Y; Toma H; Tanabe K J Urol; 2007 Oct; 178(4 Pt 1):1212-7; discussion 1217. PubMed ID: 17698147 [TBL] [Abstract][Full Text] [Related]
15. Perioperative outcomes of laparoscopic radical nephroureterectomy and regional lymphadenectomy in patients with upper urinary tract urothelial carcinoma after neoadjuvant chemotherapy. Rajput MZ; Kamat AM; Clavell-Hernandez J; Siefker-Radtke AO; Grossman HB; Dinney CP; Matin SF Urology; 2011 Jul; 78(1):61-7. PubMed ID: 21354598 [TBL] [Abstract][Full Text] [Related]
16. Lymph node yield and tumor location in patients with upper tract urothelial carcinoma undergoing nephroureterectomy affects survival: A U.S. population-based analysis (2004-2012). Chappidi MR; Kates M; Johnson MH; Hahn NM; Bivalacqua TJ; Pierorazio PM Urol Oncol; 2016 Dec; 34(12):531.e15-531.e24. PubMed ID: 27476032 [TBL] [Abstract][Full Text] [Related]
17. Clinical implications of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma. Yamashita S; Ito A; Mitsuzuka K; Tochigi T; Namima T; Soma F; Aizawa M; Ioritani N; Kaiho Y; Arai Y Int J Urol; 2016 May; 23(5):378-84. PubMed ID: 26780531 [TBL] [Abstract][Full Text] [Related]
18. Prediction of renal function after nephroureterectomy in patients with upper tract urothelial carcinoma. Hashimoto T; Ohno Y; Nakashima J; Gondo T; Nakagami Y; Namiki K; Horiguchi Y; Yoshioka K; Ohori M; Tachibana M Jpn J Clin Oncol; 2015 Nov; 45(11):1064-8. PubMed ID: 26355160 [TBL] [Abstract][Full Text] [Related]
19. Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract. Kondo T; Nakazawa H; Ito F; Hashimoto Y; Toma H; Tanabe K Urology; 2007 Feb; 69(2):265-9. PubMed ID: 17320661 [TBL] [Abstract][Full Text] [Related]
20. Role of neoadjuvant chemotherapy in patients with locally advanced and clinically positive nodes Upper Tract Urothelial Carcinoma treated with Nephroureterectomy: real-world data from the ROBUUST 2.0 Registry. Tuderti G; Mastroianni R; Proietti F; Wu Z; Wang L; Franco A; Abdollah F; Finati M; Ferro M; Tozzi M; Porpiglia F; Checcucci E; Bhanvadia R; Margulis V; Bronimann S; Singla N; Hakimi K; Derweesh IH; Correa A; Helstrom E; Mendiola DF; Gonzalgo ML; David RB; Mehrazin R; Moon SC; Rais-Bahrami S; Yong C; Sundaram CP; Tufano A; PerdonĂ S; Ghoreifi A; Moghaddam FS; Djaladat H; Ditonno F; Antonelli A; Autorino R; Simone G World J Urol; 2024 Oct; 42(1):575. PubMed ID: 39395052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]